In HCC, FOXA2 transcriptionally activate GFAT1 expression, conferring resistance to doxorubicin-induced apoptosis, with high GFAT1 levels being associated with poor prognosis of HCC [15, 16]. The gene discussed is GFPT1; the disease is hepatocellular carcinoma.